TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Bracket bond failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical course of pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Crying Time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleeping Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of MS relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlled BP after 12 weeks on triple SPC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systolic BP reduction on 4th antihypertensive drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the curve (AUC) of biomarker on HDV-RNA relapse at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integrity of report lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of lesion location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integrity of lesion in captured images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integrity of standard part in captured images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Scores on Aphasia Communication Outcome Measure
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Euroqol-5d European quality of life-5 dimensions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Measurement of pain-pressure threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of crossover from SUFB to RFB
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of serum NfL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Multidimensional Scale of Perceived Social Support (MSPSS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Patient Health Questionnaire (PHQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life (WOSI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peak hyperemic perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants achieving HI-E response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Major failure
Endpoint domain: Mortality/survival
Primary endpoint: Anxiety and depression assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numeric Rating Scale for Clinical Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Choice Made
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change from baseline sexual function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change from baseline degree of pelvic organ prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline overall health and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Birth Asphyxia
Endpoint domain: Mortality/survival
Primary endpoint: Glucose concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C-peptide level in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Autoantigen specific T cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pediatric Berg balance scale (PBBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Independent Measures (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mass Balance Recovery Measured Through Total Radioactivity Excreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Concentration-Time Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Activity Score (DAS-28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MG-specific Activities of Daily Living scale (MG-ADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MG quality of life 15 (MG-QOL15)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in MG manual muscle testing (MG-MMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cholesterol Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Jaw Functional Limitation Scale - 8 item (JFLS-8)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Successful Opening of the BBB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The quality of postoperative pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-biopsy Pain (VAS-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-biopsy Anxiety (VAS-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-biopsy Anxiety Traits (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of congenital hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Global incidence of renal adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of antibiotic treatment episodes for UTIs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Leicester Cough Questionnaire (LCQ) scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Montreal Cognitive Assessment (MoCA) scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fatigue Severity Scale (FSS) scale scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in food intake by weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SarsCOV2 Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Accuracy of fully guided implant placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with Treatment-Emergent Adverse Events (TEAEs) or Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-time curve (AUC0-0.5h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of CTCAE 4.0
Endpoint domain: Adverse events/effects
Primary endpoint: Shift of Center of Ventilation (CoV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Definition of success of neuromodulation for pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Forced Expiratory volume in 1sec (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent signal change in VTA BOLD activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Recurrence rate after LDLT
Endpoint domain: Mortality/survival
Primary endpoint: Changes in musculoskeletal health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFS (Disease-Free Survival)
Endpoint domain: Mortality/survival
Primary endpoint: Change in angle of kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Meeting guidelines for physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: weekly physical activity volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative recovery status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy outcome at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of any adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Use of effective contraception
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Assisted decongestion success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perinatal grief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Optimal PEEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perceived Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IoU and Dice Coefficient values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (Visual Analogue Pain Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Pain Catastrophization Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Range of flexion ankle dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upgrading to a dual-chamber pacemaker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Oral Disease Severity Score (ODSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS (visual analogical score) pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: axial length elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Satisfaction Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family Satisfaction Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthcare Professionals' Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quantification of HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean deviation results of visual field parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pattern standard deviation results of visual field parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity results of visual field parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hindering factors in physical activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: COVID-19 fatality rate in cancer population
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 fatality rate in different tumour types
Endpoint domain: Mortality/survival
Primary endpoint: Compliance to olive oil intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient survival and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge and attitude toward dental treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients without progression at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAIN-SS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Area Under the Viral Load-Time Curve (VL-AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median Area Under the Viral Load-Time Curve (VL-AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-month Progression-free Survival (PFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in N-terminal pro B-type natriuretic peptide (NT-proBNP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breast cancer screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Histopathological complete resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain NRS-R area under the curve through 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized bleeding event rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized treated bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized heavy menstrual bleed rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported negative affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in respiratory sinus arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Response Rate: Cohort A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate: Cohort B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of hemophagocytic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bodyweight measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion Rate of ESG Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the mindfulness course
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the mindfulness course
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effectiveness of the mindfulness course
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Muscular Oxygen Saturation (SmO2 - %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Capillary Haemoglobin (ThB - g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Oxygen-loaded capillary haemoglobin (O2HHb - g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes of FOSQ-10 as an indicator of sleep-related quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: The effect of sleep apnea treatment on blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Contributing factors to adherence rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Spinal curvature abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: myopic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change from baseline keratinized mucosa width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HFNC duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readmission for HF
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fitness (VO2 in ml/kg/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemostatic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Trapeziometacarpal pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugel Meyer assessment scale for lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Up and Down Stair Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HbA1c level between baseline and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in HbA1c level between baseline and 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Respiratory Muscle Sarcopenia Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Practice of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of scheduled patient visits kept (1-day)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of scheduled patient visits kept (7-day)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients with suppressed VL (measured VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with suppressed VL (scheduled VL measurement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of leukocyte cell surface markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phrenic nerve conduction study: motor latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phrenic nerve conduction study: Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sagital Knee Kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of fatal cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of clinically significant cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Implementation of study protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: General Anxiety Disorder (GAD - 7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Undetectable minimal residual disease (MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VOC spectra
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Dose-limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes from baseline in routine blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of DLT events
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) or maximum applicable dose (MAD)
Endpoint domain: Adverse events/effects
Primary endpoint: Soft Tissue Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buccal Bone Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency and severity of SAEs and CS-101 related AES
Endpoint domain: Adverse events/effects
Primary endpoint: Endoplasmic reticulum stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of persistent atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean maximum knee extension in the gait cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in maximum knee extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of participants screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants who consent or not consent to participate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of sessions participants attend
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: stiffness and strain character of tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Average Mean Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood Pressure Information Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-Managed Learning Skills Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Headache classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent change in radiographic airway lumen volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Effectiveness of ultrasound in determining gastric feeding tube position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse event incidence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary protein ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes